RESULTS For both sexes, the prevalence
of elevated triglycerides, reduced HDL, and elevated fasting
glucose significantly decreased with increasing quintiles of SVR
(P for trend < 0.05). The prevalence and odds ratios of
MetS significantly decreased as the SVR increased (men: odds ratio
0.5 [95% CI 0.3–0.7]; women: 0.2 [0.1–0.5]
RESULTS OGTTs (101) were available (59
male/42 female; age 5.8–22 years, percent predicted FEV1
= 94.5 ± 18%, BMI percentile = 52 ± 25%). With the use of PG2, 91
OGTT were normal, eight were IGT, and two were CFRD. With the use
of PG1 (n = 89), 39 OGTT were normal, 36 were PG1 ≥140
<200 mg/dL, and 14 were PG1 ≥200 mg/dL. PG1 was
negatively...
Fearing
the negative associations that may be attached to type 2 diabetes, some of those with
type 1 diabetes are pushing for a
change in classification so that their disease can be viewed
as...
Aims: This web resource aims to offer practical
support, templates, information and case studies for diabetes
commissioners and health care professionals to enhance the World
Class Commissioning skills and capability to deliver the Diabetes
National Service Framework.
The principles of the diabetes commissioning approach are
summarised in the document Diabetes Without Walls.
This is supported by a set of...
RESEARCH DESIGN AND METHODS A total of
1,414 African Americans (35% men; mean age 58 years) from the JHS
underwent computed tomographic assessment of PAT and abdominal
visceral adipose tissue (VAT) from 2007 to 2009 and
echocardiography examination between 2000 and 2004.
Echocardiographic measures of left atrial (LA) internal diameter,
LV mass, LV...
RESEARCH DESIGN AND METHODS This
randomized multicenter trial compared the safety and efficacy of a
basal bolus insulin regimen with glargine once daily and glulisine
before meals (n = 104) to sliding scale regular insulin
(SSI) four times daily (n = 107) in patients with type 2
diabetes mellitus undergoing general surgery. Outcomes included
differences...
The
number of individuals receiving care for type 1 and type 2 diabetes more than doubled
since the past decade, and the cost of caring for these patients is
continuing to spiral out of control, according to a new report from
the Agency for Healthcare Research and Quality.
